Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Mian

Showing results (71-80 of 83) with videos related to

Pageof 9
Sort By:
International Journal of Radiation Oncology, Biology, Physics|January 17, 2019
Analysis of the 2017 American Society for Radiation Oncology (ASTRO) Research PortfolioJames B Yu, Tyler F Beck, Mitchell S Anscher, et al.
Journal of Neurosurgery. Pediatrics|February 11, 2022
Genetic and histopathological associations with outcome in pediatric pilocytic astrocytomaSamuel J Cler, Alexander Skidmore, Alexander T Yahanda, et al.
The Journal of Urology|October 13, 2021
Patients with Muscle-Invasive Bladder Cancer with Nonluminal Subtype Derive Greatest Benefit from Platinum Based Neoadjuvant ChemotherapyYair Lotan, Joep J de Jong, Vinnie Y T Liu, et al.
Advances in Radiation Oncology|October 30, 2018
Improving prediction of surgical resectability over current staging guidelines in patients with pancreatic cancer who receive stereotactic body radiation therapyZhi Cheng, Lauren M Rosati, Linda Chen, et al.
JCO Clinical Cancer Informatics|June 18, 2025
Artificial Intelligence-Based Digital Histologic Classifier for Prostate Cancer Risk Stratification: Independent Blinded Validation in Patients Treated With Radical ProstatectomyMagdalena Fay, Ross S Liao, Zaeem M Lone, et al.
Urologic Oncology|December 9, 2019
Validation of a neuroendocrine-like classifier confirms poor outcomes in patients with bladder cancer treated with cisplatin-based neoadjuvant chemotherapyPetros Grivas, Tarek A Bismar, Aijai S Alva, et al.
The Journal of Clinical Investigation|November 15, 2023
Intratumoral androgen biosynthesis associated with 3β-hydroxysteroid dehydrogenase 1 promotes resistance to radiotherapy in prostate cancerShinjini Ganguly, Zaeem Lone, Andrew Muskara, et al.
Blood Cancer Discovery|March 8, 2021
A Therapeutic Strategy for Preferential Targeting of TET2 Mutant and TET-dioxygenase Deficient Cells in Myeloid NeoplasmsYihong Guan, Anand D Tiwari, James G Phillips, et al.
JAMA Oncology|March 14, 2024
Noninferiority of Hypofractionated vs Conventional Postprostatectomy Radiotherapy for Genitourinary and Gastrointestinal Symptoms: The NRG-GU003 Phase 3 Randomized Clinical TrialMark K Buyyounouski, Stephanie L Pugh, Ronald C Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 18, 2018
Transcriptomic and Protein Analysis of Small-cell Bladder Cancer (SCBC) Identifies Prognostic Biomarkers and DLL3 as a Relevant Therapeutic TargetVadim S Koshkin, Jorge A Garcia, Jordan Reynolds, et al.
Pageof 9

Showing results (71-80 of 83) with videos related to

Sort By:
Pageof 9
International Journal of Radiation Oncology, Biology, Physics|January 17, 2019
Analysis of the 2017 American Society for Radiation Oncology (ASTRO) Research PortfolioJames B Yu, Tyler F Beck, Mitchell S Anscher, et al.
Journal of Neurosurgery. Pediatrics|February 11, 2022
Genetic and histopathological associations with outcome in pediatric pilocytic astrocytomaSamuel J Cler, Alexander Skidmore, Alexander T Yahanda, et al.
The Journal of Urology|October 13, 2021
Patients with Muscle-Invasive Bladder Cancer with Nonluminal Subtype Derive Greatest Benefit from Platinum Based Neoadjuvant ChemotherapyYair Lotan, Joep J de Jong, Vinnie Y T Liu, et al.
Advances in Radiation Oncology|October 30, 2018
Improving prediction of surgical resectability over current staging guidelines in patients with pancreatic cancer who receive stereotactic body radiation therapyZhi Cheng, Lauren M Rosati, Linda Chen, et al.
JCO Clinical Cancer Informatics|June 18, 2025
Artificial Intelligence-Based Digital Histologic Classifier for Prostate Cancer Risk Stratification: Independent Blinded Validation in Patients Treated With Radical ProstatectomyMagdalena Fay, Ross S Liao, Zaeem M Lone, et al.
Urologic Oncology|December 9, 2019
Validation of a neuroendocrine-like classifier confirms poor outcomes in patients with bladder cancer treated with cisplatin-based neoadjuvant chemotherapyPetros Grivas, Tarek A Bismar, Aijai S Alva, et al.
The Journal of Clinical Investigation|November 15, 2023
Intratumoral androgen biosynthesis associated with 3β-hydroxysteroid dehydrogenase 1 promotes resistance to radiotherapy in prostate cancerShinjini Ganguly, Zaeem Lone, Andrew Muskara, et al.
Blood Cancer Discovery|March 8, 2021
A Therapeutic Strategy for Preferential Targeting of TET2 Mutant and TET-dioxygenase Deficient Cells in Myeloid NeoplasmsYihong Guan, Anand D Tiwari, James G Phillips, et al.
JAMA Oncology|March 14, 2024
Noninferiority of Hypofractionated vs Conventional Postprostatectomy Radiotherapy for Genitourinary and Gastrointestinal Symptoms: The NRG-GU003 Phase 3 Randomized Clinical TrialMark K Buyyounouski, Stephanie L Pugh, Ronald C Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 18, 2018
Transcriptomic and Protein Analysis of Small-cell Bladder Cancer (SCBC) Identifies Prognostic Biomarkers and DLL3 as a Relevant Therapeutic TargetVadim S Koshkin, Jorge A Garcia, Jordan Reynolds, et al.
Pageof 9